Loane Warpelin-Decrausaz

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


16 publications

2024 | 2021 | 2020 | 2018 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
2024
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Miauton A., Audran R., Besson J., Maby-El Hajjami H., Karlen M., Warpelin-Decrausaz L., Sene L., Schaufelberger S., Faivre V., Faouzi M. et al., 2024/01. EBioMedicine, 99 p. 104922. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0113C1CF1BB7]
2021
 
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium, Pan H., Peto R., Henao-Restrepo A.M., Preziosi M.P., Sathiyamoorthy V., Abdool Karim Q., Alejandria M.M., Hernández García C., Kieny M.P. et al., 2021/02/11. The New England Journal of Medicine, 384 (6) pp. 497-511. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AE3C5BFF9D70]
Informed consent in critically ill adults participating to a randomized trial.
Guinchard M., Warpelin-Decrausaz L., Schindler K., Rüegg S., Oddo M., Novy J., Alvarez V., Rossetti A.O., 2021/02. Brain and behavior, 11 (2) pp. e01965. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D1FD84C9F556]
2020
Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure : A Multicenter Randomized Clinical Trial
Rossetti Andrea O., Schindler Kaspar, Sutter Raoul, Rüegg Stephan, Zubler Frédéric, Novy Jan, Oddo Mauro, Warpelin-Decrausaz Loane, Alvarez Vincent, 2020/10/01. JAMA Neurology, 77 (10) p. 1225. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F459A59CD145]
2018
Does Continuous Video-EEG in Patients With Altered Consciousness Improve Patient Outcome? Current Evidence and Randomized Controlled Trial Design.
Rossetti A.O., Schindler K., Alvarez V., Sutter R., Novy J., Oddo M., Warpelin-Decrausaz L., Rüegg S., 2018/09. Journal of clinical neurophysiology, 35 (5) pp. 359-364. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_220E849B159B]
2016
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.
De Santis O., Audran R., Pothin E., Warpelin-Decrausaz L., Vallotton L., Wuerzner G., Cochet C., Estoppey D., Steiner-Monard V., Lonchampt S. et al., 2016. Lancet. Infectious Diseases, 16 (3) pp. 311-320. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1B0E90763307]
2014
 
Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.
Domingos-Pereira S., Derré L., Warpelin-Decrausaz L., Haefliger J.A., Romero P., Jichlinski P., Nardelli-Haefliger D., 2014. Journal of Urology, 191 (3) pp. 814-822.
[URN][DOI][WoS][Pmid][serval:BIB_5CCCD4E4842E]
2013
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.
Decrausaz L., Pythoud C., Domingos-Pereira S., Derré L., Jichlinski P., Nardelli-Haefliger D., 2013. Oncoimmunology, 2 (1) pp. e22944.
[URN][DOI][WoS][Pmid][serval:BIB_5658EE1F539B]
2012
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2012. Mucosal Immunology, 6 (2) pp. 393-404.
[URN][DOI][WoS][Pmid][serval:BIB_688E4F5E989B]
2011
 
A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
Decrausaz L., Gonçalves A.R., Domingos-Pereira S., Pythoud C., Stehle J.C., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 128 (9) pp. 2105-2113.
[DOI][WoS][Pmid][serval:BIB_AF6C31E8EF7B]
 
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD (T-cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. dans Society for Immunotherapy of Cancer SITC 26th Annual Meeting.
[serval:BIB_14A731BF59A8]
 
Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
Decrausaz L., Domingos-Pereira S., Duc M., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 129 (3) pp. 762-772.
[DOI][WoS][Pmid][serval:BIB_449929460973]
2010
 
Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
Decrausaz L., Revaz V., Bobst M., Corthésy B., Romero P., Nardelli-Haefliger D., 2010. International Journal of Cancer, 126 (10) pp. 2469-2478.
[DOI][WoS][Pmid][serval:BIB_C8FA50D44220]
2009
 
Diagnosis by culture and PCR of Salmonella abortusovis infection under clinical conditions in aborting sheep in Switzerland.
Belloy L., Decrausaz L., Boujon P., Hächler H., Waldvogel A.S., 2009/09/18. Veterinary microbiology, 138 (3-4) pp. 373-377. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CABB0B335D7]
 
Immunothérapie des cancers de la vessie dans des modèles murins: vaccination et administration locale d'immunostimulants : P117
Domingos-Pereira S., Decrausaz L., Bobst M., Jichlinski P., Nardelli-Haefliger D., 2009. dans 65e Assemblée Annuelle de la Société Suisse d'Urologie.
[serval:BIB_28080B0C758B]
2008
 
E7-specific CD8 T-cell immune responses in the genital mucosa of mice vaccinated against HPV-16 and cervical cancer : 47
Decrausaz L., Duc M., Bobst M., Zosso N., Nardelli-Haeffiger D., 2008. pp. 10S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_8B817A7F56BA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University